Summary
Updated Aug 31, 2026
Craig A. Johnson is Director of Aurinia Pharmaceuticals Inc. (AUPH). 4 SEC Form 4 filings on record going back to 2024, most recently on 8 June 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Craig A. Johnson has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Craig A. Johnson go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Craig A. Johnson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin Tang - $25.14M of AUPH open-market activity in the last 12 months
- Stephen P. Robertson - $356K of AUPH open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Craig A. Johnson?
Craig A. Johnson is a corporate insider, tracked as Director of Aurinia Pharmaceuticals Inc. (AUPH). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Craig A. Johnson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Craig A. Johnson's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Craig A. Johnson and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial